EMG
CALA

Ellington Management Group’s Calithera Biosciences, Inc CALA Stock Holding History

Ellington Management Group’s Portfolio CALA Stock Details CALA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-555
Closed -$70K – 951
2018
Q1 		$70K Sell
555
-590
-52% -$92K 0.01% 786
2017
Q4 		$191K Buy
+1,145
New +$293K 0.03% 495
2017
Q2 		– Sell
-1,045
Closed -$241K – 973
2017
Q1 		$241K Buy
+1,045
New +$181K 0.01% 522
2015
Q3 		– Sell
-3,994
Closed -$570K – 951
2015
Q2 		$570K Buy
+3,994
New +$926K 0.14% 204

Other funds holding CALA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TA
Teachers Advisors New York $81.7B AUM 13.62% 1-Year Est. Return

Ellington Management Group's CALA Position: Q2 2018 in Review

Ellington Management Group sold out of Calithera Biosciences, Inc (CALA) in Q2 2018, closing a stake of 555 shares — an estimated $70K sold.

Ellington Management Group first reported a position in CALA in Q2 2015 and held it in 4 quarters. The position peaked at $570K in Q2 2015. 90 funds tracked by Wall St. Rank hold CALA as of Q2 2018.

  • Ellington Management Group reported no remaining Calithera Biosciences, Inc position as of Q2 2018 after selling out during the quarter.
  • Ellington Management Group sold 555 Calithera Biosciences, Inc shares in Q2 2018, an estimated $70K.
  • Ellington Management Group first reported a position in Calithera Biosciences, Inc in Q2 2015 and held it in 4 quarters.
  • Ellington Management Group's Calithera Biosciences, Inc position peaked at $570K in Q2 2015.
  • 90 funds tracked by Wall St. Rank held Calithera Biosciences, Inc as of Q2 2018.

Based on Ellington Management Group's 13F filing for Q2 2018, filed 14 Aug 2018.